Diabetes Discourse

The artificial pancreas project lead by the Juvenile Diabetes Research Foundation has made tremendous progress towards eventual outpatient clinical studies. A recent panel of experts met with the FDA and NIH to determine appropriate guidelines. What are regulatory guidelines for the artificial pancreas project? Join guest host Dr. Timothy Bailey and his guest, Assistant Vice President and Director of Glucose Control Research at the Juvenile Diabetes Research Foundation, Dr. Aaron Kowalski as they discuss developments from controlled inpatient settings to real-world conditions and the need for regulation.

New screening standards for gestational diabetes could significantly increase the number of women and babies we identify as at-risk. Guest host Dr. Timothy Bailey talks with Dr. Thomas Moore, chairman of the department of reproductive medicine at the University of California, San Diego, about diabetes in pregnancy, and how gestational diabetes affects infant, childhood, and even adolescent obesity and overall health. They discusses screening methods for gestational diabetes, who is at risk, and the benefit from dietary interventions.

How can we prevent and treat pre-diabetes? Can a pill delay or prevent the onset of disease in high-risk individuals? Host Dr. Steven Edelman talks to Dr. Sunder Mudaliar, clinical professor of medicine in the division of endocrinology and metabolsim at the VA Medical Center and University of California San Diego School of Medicine, about the data on pioglitazone for diabetes prevention and the results of the ACT NOW study.

Biosimilar insulin is an attractive market to a number of American and European pharmaceutical companies. Biosimilar insulin manufacture is complicated for a number of reasons. Guest host Dr. Timothy Bailey talks with Dr. Lutz Heinemann, director of scientific services at Profil Institute for Clinical Research in San Diego and headquartered in Neuss, Germany, about the challenges and guidelines around producing safe and effective biosimilars. And, for healthcare providers, what are the practical aspects of switching to a biosimilar insulin?

About half of men with diabetes experience some kind of sexual dysfunction, and the numbers for women are not far behind. This week's guest, Janis Roszler, ceritified diabetes educator and marriage and family therapist, discusses the connection between sexual function and both physical and emotional well-being in patients living with diabetes. She makes the case for adding sexual function to the list of issues we talk about with patients who have diabetes. What are the causes of sexual dysfunction in these patients? Could drugs that help men also help women? Dr. Steven Edleman hosts.

A new study suggests newly trained physicians may not be adequately prepared to treat patients with diabetes. Host Dr. Steven Edelman, talks with Dr. Stephen Ponder, pediatric endocrinologist at Texas A&M, with 27 years of professional experience in the management of children with diabetes, about the implications for the next generation of patients and Dr. Ponder's recommendations for a mentoring system to provide additional training to young physicians.

Insulin pump practice studies reveal new approaches in the management of diabetes, including carb-counting, carb boluses, hypoglycemia and transdermal insulin drug delivery. What are actual pump practices that lead to improved control? Join host Dr. Steven Edelman and his guest, John Walsh, PA, and certified diabetes educator at Advanced Metabolic Care and Research in Escondido, California, as they discuss pump practices that lead to improved control.

The transition from hospital to home for patients with diabetes can be challenging, from glycemic targets, guidelines for initiating insulin therapy, the various types of insulin and oral agents to general nutrition. What are the current recommendations for the transition from hospital to home for patients living with diabetes? Join host Dr. Steven Edelman and his guest, Dr. Jane Jeffrie Seley, diabetes nurse practitioner and certified diabetes educator at New York-Presbyterian Hospital Weill Cornell Medical Center, as they discuss the differences in the current AACE and ADA inpatient and outpatient recommendations.

Insulin therapy can be challenging for both the patient with diabetes and their healthcare provider— from needle phobia to weight gain. How can healthcare providers shorten the learning curve to understanding insulin and its benefits? Join host Dr. Steven Edelman and his guest, Dr. Linda Siminerio, associate professor at the University of Pittsburgh School of Medicine, as they discuss insulin fact and fallacy for patients and providers.

Antipsychotic medications have dramatically increased in prescriptions, including additional FDA-approved usages for bipolar and depression as well as off-label use. Side effects of these drugs, such as abdominal weight gain, lipid and blood pressure changes, and elevations in fasting glucose, may contribute to metabolic syndrome. What are the impacts of increased use of antipsychotic medications on diabetes? Join host Dr. Steven Edelman and his guest, associate professor of psychiatry at Harvard Medical School, Dr. David Henderson, as they discuss the need for healthcare providers to be proactive: understanding the patient's risk factors, medical history and the risk-benefit ratio in order to treat effectively.